Northern Trust’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.3K | Hold |
66,609
| – | – | ﹤0.01% | 4246 |
|
|
2025
Q1 | $48.3K | Buy |
66,609
+27,401
| +70% | +$19.8K | ﹤0.01% | 4235 |
|
|
2024
Q4 | $37.4K | Hold |
39,208
| – | – | ﹤0.01% | 4301 |
|
|
2024
Q3 | $30.9K | Hold |
39,208
| – | – | ﹤0.01% | 4280 |
|
|
2024
Q2 | $37.2K | Buy |
39,208
+21,410
| +120% | +$20.3K | ﹤0.01% | 4250 |
|
|
2024
Q1 | $19.2K | Hold |
17,798
| – | – | ﹤0.01% | 4335 |
|
|
2023
Q4 | $9.79K | Hold |
17,798
| – | – | ﹤0.01% | 4420 |
|
|
2023
Q3 | $37.6K | Hold |
17,798
| – | – | ﹤0.01% | 4233 |
|
|
2023
Q2 | $46.6K | Buy |
17,798
+901
| +5% | +$2.36K | ﹤0.01% | 4235 |
|
|
2023
Q1 | $53.6K | Buy |
16,897
+3,997
| +31% | +$12.7K | ﹤0.01% | 4250 |
|
|
2022
Q4 | $34.7K | Hold |
12,900
| – | – | ﹤0.01% | 4376 |
|
|
2022
Q3 | $38K | Hold |
12,900
| – | – | ﹤0.01% | 4399 |
|
|
2022
Q2 | $38K | Sell |
12,900
-50,673
| -80% | -$149K | ﹤0.01% | 4480 |
|
|
2022
Q1 | $449K | Buy |
63,573
+539
| +0.9% | +$3.81K | ﹤0.01% | 3779 |
|
|
2021
Q4 | $1.01M | Buy |
+63,034
| New | +$1.01M | ﹤0.01% | 3542 |
|